Literature DB >> 6791002

Overview of human pharmacokinetics of naltrexone.

V Licko.   

Abstract

Experimental data on 3H labelled naltrexone obtained from the Research Triangle Institute were analyzed. Both plasma and urine curves were resolved into their exponential components. Mean total clearance of unconjugated naltrexone was 3510 (300) ml/min, and its mean urinary clearance was 76.0 (6.8) ml/min. Fraction of dose excreted through urine was between 55 and 60%. Orally administered drug is completely absorbed into plasma. Plasma curve resulting from intravenous administration contained three exponentials: 1.9 (.5)/min, 0.18 (.07)/min and 0.00106 (.00008)/min. Distribution volumes were 7.6 (.7) liters, 60 (12) liters and 164 (16) liters. After oral administration there were two exponentials: 0.012 (.002/min and 0.00122 (.00009)/min. The faster exponential corresponds to gastrointestinal absorption with a half life of about 1 hour.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791002

Source DB:  PubMed          Journal:  NIDA Res Monogr        ISSN: 1046-9516


  5 in total

1.  Mediation of the behavioral effects of ketamine and (2R,6R)-hydroxynorketamine in mice by kappa opioid receptors.

Authors:  Hildegard A Wulf; Caroline A Browne; Carlos A Zarate; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2022-04-23       Impact factor: 4.530

2.  Effects of opioid blockade on nociceptive flexion reflex thresholds and nociceptive responding in hypertensive and normotensive individuals.

Authors:  Louisa Edwards; Christopher Ring; Christopher R France; David McIntyre; Una Martin
Journal:  Int J Psychophysiol       Date:  2008-03-15       Impact factor: 2.997

3.  Microneedles permit transdermal delivery of a skin-impermeant medication to humans.

Authors:  Daniel P Wermeling; Stan L Banks; David A Hudson; Harvinder S Gill; Jyoti Gupta; Mark R Prausnitz; Audra L Stinchcomb
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-04       Impact factor: 11.205

4.  Long-acting injectable naltrexone for the management of patients with opioid dependence.

Authors:  Kimberly L Kjome; F Gerard Moeller
Journal:  Subst Abuse       Date:  2011-02-06

5.  Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.

Authors:  Paolo Mannelli; Kathleen S Peindl; Li-Tzy Wu
Journal:  Subst Abuse Rehabil       Date:  2011-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.